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ABSTRACT
Bacterial biofilm represents a major problem in medicine. They colonize and damage medical devices
and implants and, in many cases, foster development of multidrug-resistant microorganisms. Biofilm
development starts by bacterial attachment to the surface and the production of extracellular poly-
meric substances (EPS). The EPS forms a structural scaffold for dividing bacterial cells. The EPS layers
also play a protective role, preventing the access of antibiotics to biofilm-associated microorganisms.
The aim of this work was to investigate the production nanoparticles that could be used to inhibit bio-
film formation. The applied production procedure from rhizome extracts of Rhodiola rosea is simple
and environmentally friendly, as it requires no additional reducing, stabilizing and capping agents. The
produced nanoparticles were stable and crystalline in nature with an average diameter of 13–17nm for
gold nanoparticles (AuNPs) and 15–30nm for silver nanoparticles (AgNPs). Inductively coupled plasma
mass spectrometry analysis revealed the concentration of synthesized nanoparticles as 3.3 and 5.3mg/
ml for AuNPs and AgNPs, respectively. Fourier-transform infrared spectroscopy detected the presence
of flavonoids, terpenes and phenols on the nanoparticle surface, which could be responsible for reduc-
ing the Au and Ag salts to nanoparticles and further stabilizing them. Furthermore, we explored
the AgNPs for inhibition of Pseudomonas aeruginosa and Escherichia coli biofilms. AgNPs exhibited
minimum inhibitory concentrations of 50 and 100mg/ml, against P. aeruginosa and E. coli, respectively.
The respective minimum bactericidal concentrations were 100 and 200mg/ml. These results suggest
that using the rhizome extracts of the medicinal plant R. rosea represents a viable route for green
production of nanoparticles with anti-biofilm effects.
GRAPHICAL ABSTRACT
A schematic representation of the green synthesis, characterization and biofilm inhibition application
of nanoparticles produced by extracts of R. rosea.
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Introduction
Bacterial biofilms represent a significant problem in medicine.
They are the cause of several human diseases, such as the
native valve endocarditis, pneumonia in cystic fibrosis
patients, and infection of chronic wounds and chronic otitis
media. Bacterial biofilms colonize and damage a wide variety
of medical implants and devices. Inside biofilms, bacteria
often become highly resistant to antibiotics [1,2]. A variety of
microorganisms have been found to play a crucial role in
developing biofilms such as Pseudomonas aeruginosa,
Staphylococcus epidermidis, Staphylococcus aureus, and
Escherichia coli [3]. The exact mechanism by which biofilm-
associated microorganisms elicit disease are poorly under-
stood; however, the literature suggests that detachment of
cells or cell aggregates, endotoxin production and resistance
against the host immune system contribute to these proc-
esses [4].
Most of the currently used antibiotics are becoming
inefficient against the biofilm-associated multidrug-resistant
microorganisms. Therefore, it has become necessary to
search for alternative approaches to mitigate biofilm associ-
ated problems [5]. Recently, many organic and inorganic
nanoparticles have been explored for biofilm inhibition [6].
Nanoparticles exhibit antimicrobial properties due to their
unique parameters, such as ultra-fine size, specific morph-
ology, high surface area to volume ratio and presence of
biochemical moieties on their surface (functional groups or
surface coatings). These parameters define the therapeutic
or adverse effects of nanoparticles [7], for instance,
Ramasamy et al. demonstrated that cinnamaldehyde immo-
bilized gold nanoparticles (AuNPs) exhibit effective biofilm
inhibition of up to >80% against Gram-positive bacteria
(methicillin-sensitive and -resistant strains of S. aureus,
MSSA and MRSA, respectively), Gram-negative bacteria
(E. coli and P. aeruginosa) and the fungus Candida albicans
[5,8,9]. Rajkumari et al. showed that anisotropic AuNPs
reduce the biofilm formation by P. aeruginosa by over 78%
[9], Shafreen et al. reported for silver nanoparticles (AgNPs)
an inhibitory concentration of 300 ng/ml against a biofilm
formed by E. coli [10]. The antimicrobial effects of AgNPs
have been more widely established against a broad range
of multidrug resistant microorganisms [11,12]. AgNPs not
only kills the microorganisms but also play an important
role in disintegrating biofilms [13].
The medicinal plant Rhodiola rosea (Roseroot, golden root
or arctic root) belongs to the Rhodiola genus, Crassulaceae
family, and it grows on mountains in the northern regions of
Asia, North America and Europe. Multiple uses of R. rosea in
traditional medicine of different regions have been reported,
such as treating mental and physical fatigue, stress-induced
depression, anxiety and high-altitude sickness [14–16]. In this
study, for the first time, we examined the potential of aque-
ous rhizome extracts of R. rosea for synthesizing AuNPs and
AgNPs. We demonstrate that the nanoparticles can be pro-
duced in an environmentally friendly setup, and that they
can be used effectively to inhibit biofilms of infec-
tious bacteria.
Materials and methods
Materials
Analytical grade gold (III) chloride trihydrate (HAuCl43H2O)
and silver nitrate (AgNO3) were purchased from Sigma-
Aldrich Chemicals.
Plant material
Rhodiola rosea seeds of Russian origin (Strictly Medicinal,
Williams, OR, US) were sterilized following standard protocols
for sterilization of Arabidopsis seeds and sown in vitro. The
medium (MS) consisted of 2.2 g l1 including vitamins
(Dushefa Biochemie BV, Haarlem, The Netherlands), 0.5 g 2-
(N-morpholino)ethanesulfonic acid (MES) (Dushefa Biochemie)
l1, 15 g sucrose l1 and 4 g Gelrite (Dushefa Biochemie) l1,
adjusted to pH 6.3 with 5M KOH. After 6months, plants were
transferred to soil. The plants were subsequently grown in 2 l
pots (Teku VCC13, P€oppelmann GmbH & Co. KG, Lohne,
Germany). The substrate used for all in vivo grown plants was
a soil-peat mixture (Plugg och Såljord Kron Mull, Weibulls
Horto AB, Hammenh€og, Sweden). All in vivo plants were kept
in a greenhouse at 23 C under natural and supplementary
light, which was provided when necessary from 7:00 to
23:00. After 1-year growth in the greenhouse, the plants
were transferred to outdoor conditions where they grew for
2 years before analyses [17].
Green synthesis of AuNPs and AgNPs
For the green synthesis of nanoparticles, a previously
reported methodology was followed [18]. The rhizome of R.
rosea was harvested and washed thoroughly with distilled
water. 10 g of rhizome was ground and boiled for 30min
with sterile water, maintaining a total volume of 100ml [19].
Particulates were removed from this aqueous extract by fil-
tration. The aqueous extract was further centrifuged at
8000 rpm for 3min to remove any fine suspended particu-
lates [20]. The crude extract was further diluted in water at
different ratios of extract to water in order to synthesize
AuNPs and AgNPs. For the nanoparticles synthesis, the opti-
mized concentration of the filter-sterilized metal salt solution
(HAuCl43H2O and AgNO3) was used, under optimal condi-
tions. The synthesis was first monitored by the visual color
change in the reaction mixture, followed by the spectral
analysis [18]. After the complete reduction in metal salts to
nanoparticles, the nanoparticles were purified by centrifuga-
tion, first at 2000 rpm for 5min, which allowed removing
the large particulates, followed by a second round of centri-
fugation at 14,000 rpm for 15min to collect the nanopar-
ticles [18,21]. The obtained nanoparticles were washed
thoroughly with distilled water to remove the unconverted
metal ions or any other reaction constituents. Finally, the
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nanoparticles were collected in the form of a pellet and re-
suspended in water for subsequent characterization
and testing.
Characterization of nanoparticles
Ultraviolet-visible spectrophotometry
Ultraviolet-visible spectrophotometer (UV-vis) (6705 UV/Vis.
Spectrophotometer, JENWAY) was used to confirm the reduc-
tion in metal ions into metal nanoparticles by scanning the
reaction suspension in a 300–700 nm range. The optimization
studies were also conducted using UV-vis by scanning the
optimizing samples at 300–700 nm [22].
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry
The presence and composition of clusters on nanoparticles
surface were studied by using matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF).
Purified nanoparticles (1ll) were loaded onto an
AnchorChipTM target plate (Bruker-Daltonics, Bremen,
Germany), covered by 1 ll of the matrix solution (0.5 lg/ll
2,5-dihydroxybenzoic acid in 90% (v/v) acetonitrile, 0.1% (v/v)
trifluoroacetic acid (TFA) and washed with 0.5% (v/v) TFA. All
analyses were performed on the MALDI-TOF mass spectrom-
eter (Ultraflex II, Bruker-Daltonics, Bremen, Germany) in a
positive ion reflector mode with 1000 laser shots per spec-
trum using Flex Control v3.4. Spectra were processed using
Flex Analysis v3.0 (Bruker-Daltonics, Bremen, Germany), and
mass calibration was performed using protein standards
(tryptic digest of b-lactoglobulin, 5 pmol/ll) [23].
Transmission electron microscopy
Transmission electron microscopy (TEM) by FEI Tecnai T20 G2,
operated at 200 kV was used to characterize the shape and
size of nanoparticles. TEM was further used for analyzing the
selected area electron diffraction (SAED) pattern of nanopar-
ticles [24]. The sample preparation involved liquid spotting
on carbon-coated copper grids, and subsequent air drying
before the samples were transferred to the microscope.
Atomic force microscopy
The atomic force microscopy (AFM) measurements (Park
NX20 from www.parkafm.com) were carried out in the inter-
mittent contact mode using standard probes of single crystal
highly doped silicon with a radius of curvature of less
than 30 nm (PointProbe PlusTM or SuperSharpSiliconTM Non-
Contact AFM probes from Nanosensors). The standard uncer-
tainty u(d) of the measured diameter was u(d)< 0.05 d for
the measured particles.
Particles size and zeta potential analysis
The particle size distribution and zeta potential of the nano-
particles were studied by dynamic light scattering (DLS)
(Zetasizer Nano ZS, Japan). Hydrodynamic diameters and pol-
ydispersity index (PDI) were analyzed at 25 C. As a reference,
a dispersive medium of pure water with a refractive index of
1.330, viscosity of 0.8872 and dielectric constant of 78.5 was
used [25].
Fourier Transform-Infrared spectroscopy
The Fourier-transform infrared spectroscopy (FT-IR) measure-
ments were conducted on FTIR, Nicolet iS50, Thermo
Scientific. The samples were prepared by air-drying the puri-
fied nanoparticles and scanning on the FT-IR instrument over
the range of 4000–450 cm1 at a resolution of 4 cm1. The
FT-IR analysis was done to study the interactions between
the functional groups present as a source of reducing, cata-
lytic and capping agents on the surface of synthesized nano-
particles. The spectra recorded were plotted as transmittance
(%) versus wavenumber (cm1) [26].
Single-particle inductively coupled plasma-mass
spectrometry
Single-particle inductively coupled plasma-mass spectrometry
(sp-ICP-MS) was used for size fractionation and quantification
of synthesized nanoparticles. Nanoparticles were measured in
single particle mode (time-resolved analysis), sp-ICP-MS
(NexION 350D, PerkinElmer). The dwell time was set to 100
ms and the scan time to 100 s. The particle size calculations
were based on the calibration curve of the dissolved metal,
which was matrix-matched with the samples (i.e. prepared in
the same medium). In brief, the signal intensity for the dis-
solved metal is correlated with the signal intensity of the par-
ticle, which allows calculations of the particle mass and
diameter, assuming that particles are spherical. The principle
of the method together with equations has been described
previously [27]. The transport efficiency was calculated based
on 60 nm particles (Perkin Elmer, USA), and the measure-
ments were conducted in the same matrix used for experi-
mental samples.
Nanoparticles stability
Particles stability over time was studied by scanning the sam-
ples in the 300-700 nm range, at time zero and after one
month. The concentration of nanoparticles was measured for
fresh nanoparticles and after two weeks difference by sp-ICP-
MS. Thermal stability of powdered nanoparticles has been
determined by the thermogravimetric analysis (TGA), on a
Discovery TGA (TA Instrument). For the TGA analysis, nano-
particles were placed in an alumina pan and heated from 20
to 700 C at a ramping time of 10 C/min.
Minimum inhibitory concentration and minimal
bactericidal concentration of nanoparticles
To evaluate the antibacterial activity of synthesized AuNPs
and AgNPs, Escherichia coli UTI 89 and Pseudomonas aerugi-
nosa PAO1 were used. Both bacterial strains were grown in
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Luria-Bertani (LB) broth. Minimum inhibitory concentration
(MIC) and minimum bactericidal concentration (MBC) of
AuNPs and AgNPs were evaluated by a microdilution
method, as described previously [28]. Briefly, bacterial cul-
tures of both strains were grown overnight and diluted to
obtain 1–2 105 colony forming units (CFUs)/ml. These were
mixed with serially diluted AuNPs and AgNPs with the final
nanoparticle concentration ranging from 6.25 mg/ml to
400mg/ml. The bacterial suspensions with nanoparticles were
incubated at 37 C for 24 h, and the optical density (OD) at
550 nm was recorded. The MIC was defined as the lowest
concentration of nanoparticles which limited the bacterial
growth at OD550¼ 0.05 or lower. For assessing the MBC, 10 ml
of samples described above were plated on agar plates and
incubated at 37 C. MBC value was defined as the lowest con-
centration of nanoparticles, which prevented any visible
growth of bacteria on agar plates.
Biofilm inhibition assay
To evaluate the effect of AuNPs and AgNPs against biofilm
formation, bacterial cultures grown overnight were diluted
with the LB broth to obtain 1–2 106 CFUs/ml. These sam-
ples were placed in 96 well plate and incubated at 37 C for
5 h. After the incubation, the old culture medium was
replaced with a fresh medium containing different concentra-
tions of AuNPs or AgNPs, without physically disrupting the
biofilm. Samples were incubated further at 37 C for 24 h.
Thereafter, the medium was removed, samples were gently
washed two times with sterile water to remove the plank-
tonic state/free floating bacteria and dried for 30min at
room temperature. The biofilms were stained with a 0.1%
solution of crystal violet for 20min. The excess stain was
removed by washing with sterile water for five times, and
stained biofilms were dried at room temperature for 1 h.
200ml absolute ethanol was then added to each stained bio-
film sample, and the mixture was agitated vigorously for
15min to extract the stain. The OD of extracted crystal violet
was measured at 590 nm.
Effect on bacterial growth
In order to examine the effect of nanoparticles on growth of
E. coli and P. aeruginosa at sub-MIC levels, bacterial growth
was monitored spectrophotometrically at 600 nm against a
culture medium blank, at selected time intervals. Briefly,
100ml of bacterial suspension from overnight culture was
sub-inoculated in the fresh medium and incubated at 37 C
in shaking incubator. AgNPs (12–100 lg/ml) were tested on
bacterial growth.
Nanoparticle coatings and bacterial adhesion assay
AgNPs were coated on 15mm glass cover slips by drop cast-
ing method [29]. Briefly, 250 ml of samples with different con-
centrations of water dispersed nanoparticles were placed on
cover glass and dried at 37 C overnight. The coated cover
glass slides were used to evaluate the effect of these nano-
particles on bacterial adhesion. 250ml of bacterial suspension
containing 1–2 106 CFUs/ml were added to the non-coated
and coated cover glass and incubated for 5 h at 37 C. After
incubation, biofilms were rinsed with sterile water and homo-
genized by sonication. The homogenized biofilm suspensions
were plated on agar plates for CFU counting. Furthermore,
adhesion of the bacterial cells on the AgNPs coated and non-
coated surface was visualized by using fluorescence micros-
copy as described previously [30]. Briefly, after a 5 h period of
bacterial adhesion, biofilms were rinsed with sterile water
and stained with the mixture of 6.0 lM SYTO 9 and 30 lM
potassium iodide from Live/Dead BacLight Viability kit
L13152 (Invitrogen, Molecular Probes, Inc. Eugene, OR) for
20min. The imaging of stained biofilms was performed by
using a fluorescence microscope (Axio Imager.Z2m Carl Zeiss,
Zena, Germany).
Statistical analysis
All assays were performed in at least three biological repli-
cates. Data are presented as the mean± standard deviation
(SD). The intergroup differences were estimated by one-way
analysis of variance, followed by a post hoc multiple compari-
son (Tukey test). Values were considered statistically signifi-
cant at p  .05.
Results and discussion
Green synthesis of nanoparticles
The synthesis methodology for AuNPs and AgNPs using R.
rosea aqueous rhizome extracts that we followed is outlined
in the graphical abstract. For the green nanoparticles synthe-
sis, the aqueous rhizome extracts of R. rosea were incubated
separately with respective metal salts at different conditions
as outlined in the materials and methods section. Plant com-
ponents such as polysaccharides, flavonoids, terpenoids, poly-
phenols, amino acids, alkaloids, organic acids and vitamins
are all known to contribute to reducing metals salts to form
nanoparticles and/or capping and stabilizing the produced
nanoparticles [26,31]. AuNPs and AgNPs were synthesized
successfully, as indicated by the color change in the reaction
suspension from light yellow to deep purple for AuNPs and
brown for AgNPs (Figure 1) [21,32,33]. The synthesis of nano-
particles was confirmed by a wavelength scan (300–700 nm)
of the nanoparticles suspension. From previous studies, it has
been suggested that the spectra in the 500–600 nm range
correspond to AuNPs and in 350–500 nm range corresponds
to AgNPs [34,35]. Both, AuNPs and AgNPs were scanned dir-
ectly in suspension and with purified nanoparticles (Figure
1(A–D)) [18]. We also investigated the purified nanoparticles
stability in suspension by scanning them after one month.
The results indicated stability of synthesized nanoparticles in
these conditions.
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Optimization of bioreduction of gold and silver ions into
nanoparticles
Reaction parameters such as the reaction mixture ratio, tem-
perature, time and concentration of metal ions have been
taken into consideration to evaluate the possibilities for effi-
cient synthesis of nanoparticles. Our results demonstrated
that a 2:8 ratio of extract to water was optimal for econom-
ical synthesis of AuNPs (Figure 2(A)). The particles synthesis
was completed at room temperature within 4 s, which shows
the economical potential of this process. The optimal time
for AuNPs synthesis in this study was 4 s, which is quite less
than in other reports, for instance, Markus et al. reported
50min for AuNPs synthesis by Angelicae pubescentis [36]. The
Figure 2. Optimization studies based on the UV-vis spectral analysis for AuNP and AgNP production by the R. rosea rhizome extract. The optimized parameters for
AuNPs were: reaction mixture ratio (extract:water) (A) and gold salt concentration (B). The optimized parameters for AgNPs were as follows: the reaction mixture
ratio (extract:water) (C), temperature (D), time (E) and silver salt concertation (F). The photograph of test tubes with optimizing concentrations is shown next to
respective figures.
Figure 1. Visible and UV-vis spectra of AuNPs (A) and AgNPs (B). The purple and brownish color with absorbance spectra at 540 and 440 nm showed the formation
of AuNPs and AgNPs in the respective reaction mixture since the color and absorbance is due to the surface plasmon resonance of synthesized nanoparticles. UV-
visible spectra showing unchanged SPR for AuNPs and AgNPs, freshly prepared nanoparticles (A,B), purified nanoparticles (C,D), at the time of synthesis and one
month after (E,F). The plant extract and nanoparticles are shown as insets in panels A and B.
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optimal gold salt concentration for AuNP synthesis was
5mM. At this concentration, the nanoparticle absorbance
peak was also most narrow, indicating nanoparticle stability
and the absence of agglomeration (Figure 2(B)). All the
obtained spectra were in agreement with visual inspection of
samples in tubes, as shown in Figure 2 [22]. For the AgNP
synthesis, the optimal reaction mixture ratio was also 2:8
extract to water (Figure 2(C)). The temperature and time
optimization studies revealed that the 90 C and 10min are
optimal for AgNPs formation (Figure 2(D,E)). Further increase
in the temperature led to degradation and precipitation in
the reaction mixture, suggesting that nanoparticles were not
stable and agglomerated at 100 C and above. For silver salt
optimization, we tested a range of salt concentration from 1
to 7mM, 5mM of silver nitrate was the optimal concentration
for AgNP synthesis. Further increase in the salt concertation
led to a significant shift of the absorbance peak (Figure 2(F)),
suggesting a loss in nanoparticles stability and aggregation.
Importantly, the optimal synthesis time for AuNPs and AgNPs
is considerable shorter than in other reports, which showed
longer time duration for nanoparticles synthesis, for instance,
Huo et al. showed that Gu-AuNp and Gu-AgClNp syntheses
take 4 and 40min by using Glycyrrhiza root extract [37]. Thus,
the optimal conditions identified for AuNPs (2:8 ratio, 5mM
HAuCl43H2O salt and room temperature) and for AgNPs (2:8
ratio, 90 C, 6mM and 10min) resulting in highest yield and
minimal agglomeration.
The synthesized nanoparticles were analyzed by MALDI-
TOF to map the composition of the capping layer. Both
AuNP and AgNP samples produced ions in the low-mass
regions of the spectra between 500 and 22,000m/z. For
AuNPs, several peaks were found to correspond to gold clus-
ter ions (197Auþ, atomic weight 196.9666 u), including
197Au3
þ (calculated value 590.8997), 197Au4
þ (787.8663),
197Au5
þ (984.8328), 197Au6
þ (1181.7993), 197Au7
þ (1378.7659),
197Au8
þ (1575.7325) and 197Au12
þ (2363.5992). These are indi-
cated in acquired spectra shown in (Figure 3(A)). For AgNPs,
several peaks could be assigned to silver cluster ions (107Agþ,
atomic weight 107.8682 u), in particular of higher cationic
species, such as 107Ag6
þ (calculated value 647.2092), 107Ag7
þ
(755.0774), 107Ag8
þ (862.9456), 107Ag9
þ (970.8138), 107Ag11
þ
(1186.5502), 107Ag13
þ (1402.2866), 107Ag15
þ (1618.023),
107Ag17
þ (1833.7594) and 107Ag19
þ (2049.4958) (Figure 3(B)).
Although a more detailed investigation is required to answer
all the biological components present on the surface, this
study provides the basic understanding of capping layer con-
tent [23].
Nanoparticles characterization
TEM observations confirmed the presence of irregularly
shaped nanoparticles for AuNPs with size ranging from 12 to
18 nm (Figure 4(A,B)), and spherical nanoparticles for AgNPs
with the size range between 12 and 30 nm (Figure 4(C,D)).
The crystallinity of the biosynthesized nanoparticles was eval-
uated by selected area (electron) diffraction (SAED) [22,33].
The multiple electron diffraction patterns corresponding to
the polycrystalline nature of the synthesized nanoparticles
were detected conforming to lattice planes of Bragg’s reflec-
tion (111), (200), (220) and (311) (Figure 4(E–H)) [24,38]. This
is in agreement with the finding reported by Abbai et al,
who characterized multifunctional Ag and AuNPs from the
oriental herbal adaptogen Siberian ginseng [26]. To comple-
ment the TEM analysis, which provides only a two-dimen-
sional image of nanoparticles, we performed AFM, which
allows for three-dimensional profiling, i.e. measurement of
nanoparticles height (Figure 4(I,J)). The AFM analysis of sam-
ples showed that the height of AuNPs was in the range of
13–17 nm and for AgNPs in the range of 15–30 nm. The
results of AFM analysis were in close correlation with the
TEM data.
The DLS analysis was performed to study the mean nano-
particle size (hydrodynamic diameter) and zeta potential,
available surface charge on nanoparticles surface, which cor-
responds to their stability (Figure 5). The hydrodynamic diam-
eter observed for AuNPs was 139.9 nm with a PDI value of
Figure 3. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) spectra for AuNPs (A) and AgNPs (B).
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0.34 (Figure 5(A)), for AgNPs the hydrodynamic diameter was
270 nm, with a PDI value of 0.28 (Figure 5(B)) [38]. Next, we
performed the zeta potential analysis to investigate the sur-
face characteristics of the synthesized nanoparticles and to
correlate this with long-term stability. High value of zeta
potential represents a higher electrical charge on the surface
of the nanoparticles, which results in substantial repulsive
forces among the nanoparticles that prevent agglomeration.
Low zeta potential facilitates aggregation due to van der
Waals inter-particle attractions. We observed a negative zeta
potential of about 18.1mV for AuNPs and 26.5mV for
AgNPs (Figure 5(C,D)), which is higher than the surface
charge required for nanoparticles stability [39]. Balakumaran
et al. showed the mycosynthesis of gold and AgNPs with the
negative zeta potential value [40]. Essam et al reported that
AgNPs produced by Bacillus licheniformis showed that the
zeta potential ranged from 16.6 to 21.3mV was quite sta-
ble, demonstrated excellent in vitro antimicrobial activity
against important human pathogens and antiviral activity
against the Bean Yellow Mosaic Virus [41]. Thus, the negative
surface charge is highly responsible for providing the col-
loidal stability to nanoparticles, especially in biological envi-
ronments [42].
Nanoparticles surface contains biomolecules from the
R. rosea extract
The specific applications of nanoparticles are limited by their
tendency to be self-aggregated during the post-synthesis
phase, which is due to the absence of capping or stabilizing
layers or unprotected nanoparticles surface. Nanoparticles
that are not synthesized in biological systems are routinely
capped with various agents such as surfactants, polymers,
dendrimers, biological templates and biomacromolecules that
protect these nanoparticles from self-aggregation. By com-
parison, the “green synthesis” of colloidal nanoparticles
involves biocompatible ingredients, which act as functionaliz-
ing ligands under physiological conditions of temperature
and pressure, making these nanoparticles more suitable for
biomedical applications, mostly due to their long-term stabil-
ity [38]. In the current study, the rhizome extract of R. rosea
provides bioactive components, which get attached on the
surface of the nanoparticles and form a capping layer. The
FT-IR measurement was carried out, to acquire further infor-
mation about the presence of biological compounds in the
nanoparticles capping layer [26]. The analysis of the FT-IR
spectrum of plant extracts and corresponding nanoparticles
suggested extensive similarities between the samples. In par-
ticular, the spectra of R. rosea rhizome extract, AuNPs,
and AgNPs are characterized by the O–H band at 3280.97,
3176.36 and 3200.61 cm1. The C–H stretching was
observed between 2932.17 and 2941.62 cm1 and a band at
1604.05, 1597.98 and 1598.12 corresponding to C=C stretch,
COOH stretch were observed. Bands at 1344.27, 1435.50,
1468.97 cm1 corresponds to CH3 and CH2 asymmetric
deformation. Moreover, C–O stretching at
1014.90–997.11 cm1 were also detected in all the samples
(Figure 6(A–C)) (Table 1). The FT-IR peaks of nanoparticles
suggest that phenolic compounds were likely to be involved
in the reduction of HAuCl43H2O and AgNO3 to AuNPs and
Figure 4. Transmission electron microscopy (TEM) images of nanoparticles showing the particle shape of AuNPs (A,B) and AgNPs (C,D) and the selected area diffrac-
tion pattern (SAED) of AuNPs (E,F) and AgNPs (G,H), with respective SAED apertures. From these images, the size of nanoparticles with crystalline nature was esti-
mated at 13–17 nm for AuNPs and 15–30 nm for AgNPs. The AFM analysis of nanoparticles for AuNPs and AgNPs is shown in panels (I) and (J), respectively.
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AgNPs, respectively. R. rosea contains several bioactive com-
pounds, responsible for its pharmacological activity. Research
has been focused on rosavin and its derivatives, which are
only present in R. rosea and salidroside, common to most
Rhodiola species [16]. However, other substances, including
flavonoids such as quercetin and gossypetin, which were
identified among others in R. rosea extracts [43], could be
involved in pharmacological activity [14–16]. The exact mech-
anism of nanoparticles synthesis from plant extract is
unknown. The literature suggests that upon addition of metal
salts to the plant extract, the metal ions rapidly bind with
the proteins and water-soluble molecules with functional
groups (such as –OH and –COOH) and are entrapped. This
led to the conformational changes in proteins and exposes
their hydrophobic residues to aqueous phases. This further
causes introduction of reducing agents from plant extract
and favors the transformations of entrapped metals into
metal nanoparticles [12,44]. Various water-soluble plant bio-
molecules contribute as reducing and capping agents in
nanoparticle production. Terpenoids, which are a class of
diverse organic polymers found in plants, have been sug-
gested to be accountable for the reduction of silver and gold
ions into nanoparticles [31,45]. Similarly, flavonoids possess
various functional groups, which are capable of reducing
metal ions into nanoparticles [21,45].
Nanoparticles stability
Unstable nanoparticles tend to form aggregates, resulting in
diminished surface area for interaction. Stability therefore
enhances the effectiveness of the nanoparticles and their
usefulness in applications, due to, e.g. improved antimicrobial
activity. We confirmed the stability of synthesized nanopar-
ticles by keeping them in solution for different time intervals
of up to a month. There was no major shift in the UV-vis
spectrum of the nanoparticles solution up to one month,
which suggested full stability of nanoparticles in an aqueous
system (Figure 1(E,F)).
Single particle ICP-MS measurements were conducted to
determine AuNPs and AgNPs concentration and size distribu-
tion in the samples at the beginning of the test and after
two weeks. For the AuNPs sample, the particle number con-
centration at the start of the test was 513 103 particles/ml,
which corresponds to 0.0449mg/l. The total gold
Figure 5. Particles size distribution of AuNPs (A) and AgNPs (B). Zeta potential analysis shows the surface charge on nanoparticles with respect to the total number
of nanoparticles present in the solution for AuNPs (C) and AgNPs (D). This study has been done in triplicates.
ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY S893
concentration, when adding the dissolved fraction (0.171 mg/
l), was 0.448mg/l. After two weeks, the particle concentration
and the dissolved gold concentration slightly increased to
622 103 particles/ml and 0.264mg/l, respectively, resulting
in a total gold concentration of 0.417mg/l. The mean size of
AuNPs in the first run and after two weeks was 34 and
31 nm, respectively. The AuNPs therefore seems to be stable
over two weeks of incubation, displaying only minor changes
in particle number and size (Figure 7(A,B)). The measured
particle number concentration for the first run for AgNPs was
62.5 103 particles/ml with the mean size of 39 nm, which
corresponds to mass concentration of 0.0449mg/l. The dis-
solved silver concentration was 0.082mg/l, resulting in total
silver concentration (i.e. particulate and dissolved) of
0.127mg/l. The measurements of the same sample after two
weeks showed decreased AgNPs size (34 nm), as well as
lower particle number concentration (37 103 particles/ml,
corresponding to 0.029mg/l) and increased dissolved silver
concentration (0.107 mg/l). The total silver concentration,
however, remained relatively unchanged at 0.136mg/l. This
indicates that, over time, AgNPs are dissolving and becoming
smaller (Figure 7(C,D)).
Additionally, TGA was conducted to measure the thermal
stability and weight loss of AuNPs and AgNPs as a function
of temperature (Figure 7(E,F)). The first observed weight loss
was attributed to the loss of entrapped water molecules on
the nanoparticles surface [46]. The thermal degradation of
nanoparticles picks up pace above 200 C, and by 700 C the
nanoparticles degrade completely. This behavior is in line
with previous reports on thermal stability of nanoparticles.
Taken together, our stability experiments showed that nano-
particles produced from R. rosea extracts are reasonably
Figure 6. FT-IR spectra of rhizome extract (A), AuNPs (B) and AgNPs (C) for the identification of functional groups and interactions between molecules and the
nanoparticle surfaces.
Table 1. Main features FT-IR spectra of R. rosea rhizome extract, AuNPs and AgNPs.
Type of bond Root extract wavenumber (cm–1) AuNP wavenumber (cm–1) AgNP wavenumber (cm–1)
O-H stretch 3280.97 3176.36 3200.61
C-H stretch 2932.17 2915.82 2941.62
C-C stretch, COOH stretch 1604.05 1597.98 1598.12
CH3, CH2 asymmetric deformation 1344.27 1435.50 1468.97
C-O stretch 1014.90 1197.87 997.11
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stable in our experimental setup for a period of up to
two weeks.
Biofilm inhibition by nanoparticles
AgNPs are known to have strong antibacterial activity against
both Gram-positive and Gram-negative bacteria [4]. Since,
the antibacterial effect is solely dependent on the method of
synthesis, size of particles, release of silver and the type of
bacterial strains, many variations in nanoparticle concentra-
tion required for antibacterial effects have been reported by
different studies [47–50]. We performed an initial antimicro-
bial evaluation of synthesized AgNPs and AuNPs by deter-
mination of MIC and MBC against E. coli and P. aeruginosa.
The obtained results demonstrate a significant antibacterial
activity of AgNPs with bacteriostatic and bactericidal effects
at the concentration of 50 and 100 mg/ml against
P. aeruginosa and 100 and 200 mg/ml against E. coli respect-
ively (Table 2). In contrast, AuNPs did not show any antibac-
terial activity against either bacterial strain even at a high
concentration of 200 mg/ml. It is well known that nanoparticle
antimicrobial efficacy is size dependent, small particles can
more easily interact to the cell surface and are internalized
into the cytoplasm due to less spatial hindrance. Additionally,
smaller nanoparticles provide greater surface area to interact
with microorganisms or biological components, thus being
more effective. AgNPs release Agþ ions via oxidation and
increase the generation of reactive oxidative species, which
damage cell components and cause cell death [51]. The small
size of our AgNPs (15–30 nm) is an additional contributing
factor to their antibacterial effect. Next, we tested the efficacy
of both AgNPs and AuNPs in inhibiting the biofilm formation
by E. coli and P. aeruginosa, in the concentration range of
1.6–200 mg/ml. As shown in Figure 8, both types of nanopar-
ticles inhibited the biofilm formation by P. aeruginosa and
E. coli at the sub-MIC concentrations. The significant inhib-
ition in biofilm formation was observed at 6.25mg/ml for
AgNPs and 12.5 mg/ml for the AuNPs. The inhibition on the
biofilm formation caused by AuNPs was particularly interest-
ing, since these particles did not have a direct bactericidal
effect. Biofilm inhibition at sub-MIC concentrations might be
due to non-lethal damage or due to inhibitory effect on
expression of genes related to motility and biofilm formation
[52,53]. As shown in Figure 9, AgNPs at sub-MIC level signifi-
cantly inhibited the growth rate of both bacterial strains, sug-
gesting significant levels of sub-lethal damage. Adhesion of
bacteria to any surface is a primary stage for biofilm forma-
tion. Since the adhesion of bacteria might be affected by sev-
eral factors such as growth environment, bacterial viability
and material surface characteristics, we evaluated the inhibi-
tory effect of AgNPs against the bacterial adhesion on a
cover glass at the sub-MIC level. AgNPs were coated on the
cover glass and incubated at 37 C with the bacterial culture.
Thereafter, viability of attached bacteria was examined by
counting CFUs and live/dead staining. As shown in Figure 10,
concentration of AgNPs used for coating was in inverse linear
dependence with adhesion of E. coli and P. aeruginosa. To
further clarify the results obtained from the adhesion assay,
Figure 7. ICP-MS measurement of AuNPs (A) and AgNPs (B) of freshly prepared nanoparticles which shows the size distribution histogram. ICP-MS measurements
were performed initially and after two weeks of incubation to analyze the nanoparticles stability for AuNPs (C) and AgNPs (D). The dwell time was set to 50 ms and
the scan time to 100s. Thermogravimetric analysis (TGA) measurement of AuNPs (E) and AgNPs (F), which shows the complete nanoparticles degradation at high
temperature.
Table 2. MIC and MBC of AgNPs against P. aeruginosa and E. coli. MIC and
MBC of AgNPs were >200lg/ml against both bacterial strains.
Bacterial strain MIC (lg/ml) MBC (lg/ml)
P. aeruginosa PA01 50 100
E. coli UTI89 100 200
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live/dead staining of adhering cells was carried out. The
results showed a partial killing effect of AgNPs at the sub-
MIC level (Figure 11). The results demonstrate that AgNPs at
sub-MIC concentrations lead to partial killing that results in
in inhibition of bacterial growth and adhesion.
Conclusion
There is a growing interest for the development of environ-
mentally benign protocols to synthesize nontoxic metallic
nanoparticles for medical or clinical purposes. This work dem-
onstrates the applicability of R. rosea rhizome extracts for
rapid and economical synthesis of AuNPs and AgNPs. We have
concluded that crystalline AuNPs and AgNPs can be synthe-
sized at quite high concentrations in the range of 3–5mg/ml,
respectively. Additionally, we demonstrated that produced
AgNPs can be effective for inhibition and disruption of bio-
films formed by P. aeruginosa and E. coli. Thus, R. rosea rhi-
zome extracts could be useful for producing nanoparticles in a
rapid and biocompatible way. In the future, we can consider
these kinds of medicinal plants with high therapeutic value
Figure 8. Effect of AuNPs and AgNPs on bacterial biofilm formation. P. aeruginosa (A, B) and E. coli (C, D). All the experiments were performed in biological tripli-
cates, data represent mean ± SD. p< .05, p< .005 and p< .001.
Figure 9. Effect of AgNPs on the growth of P. aeruginosa PA01(A) and E. coli UTI89 (B) at sub-MIC levels. All the experiments were performed in biological tripli-
cates, data represent mean ± SD.
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will create a new platform for synthesizing nanoparticles with
high concentration, crystallinity and stability.
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